Research Project
Grant-in-Aid for Challenging Research (Exploratory)
This research is aimed at revealing the role of CD69 molecule on anti-tumor immune responses, and at contributing to establish a new cancer immunotherapy. CD69 has been known to regulate lymphocyte trafficking and migration, and we found that CD69 is expressed on most tumor-specific T cells infiltrated within tumor microenvironment. Importantly, our data showed that tumor growth was significantly reduced in Cd69-deficient mice as well as the mice with anti-CD69 Ab treatment, which was accompanied with enhanced anti-tumor immune responses. Our results show that CD69 is a new target for cancer immunotherapy.
患者自身の免疫システムを活性化することにより腫瘍を攻撃する「免疫療法」は、近年目覚ましい開発が進められており、今後、さらに大きな発展が期待される。しかしその一方で、現行の免疫チェックポイント阻害剤の適応にならないがん腫や、副作用の問題、禁忌症などがあることから、新たな免疫療法の開発が常に求められている。本研究は「CD69」というT細胞の動態システムに重要な働きをする分子に着目し、新しいがん免疫療法の確立を目指したものである。従来の免疫チェックポイント阻害薬とは、一線を画した斬新なアイディアを基にしたものであり、学術的意義、社会的意義の高い研究である。
All 2020 2019 2018 Other
All Journal Article (7 results) (of which Int'l Joint Research: 4 results, Peer Reviewed: 7 results, Open Access: 7 results) Presentation (15 results) (of which Int'l Joint Research: 7 results, Invited: 7 results) Remarks (2 results)
Frontiers in Immunology
Volume: 10 Pages: 3125-3125
10.3389/fimmu.2019.03125
Seminars in Immunopathology
Volume: - Issue: 3 Pages: 349-358
10.1007/s00281-019-00734-7
Volume: 10 Pages: 955-955
10.3389/fimmu.2019.00955
Journal of Allergy and Clinical Immunology
Volume: 0091-6749(19) Issue: 2 Pages: 30340-9
10.1016/j.jaci.2019.02.024
Chiba medical journal
Volume: 94E Issue: 3 Pages: 19-23
10.20776/S03035476-94E-3-P19
120006489910
https://opac.ll.chiba-u.jp/da/curator/105204/
Nature Communications
Volume: 9 Issue: 1 Pages: 3749-3749
10.1038/s41467-018-06283-1
International Immunology
Volume: 30 Issue: 12 Pages: 559-567
10.1093/intimm/dxy050
https://www.m.chiba-u.ac.jp/class/meneki/jisseki/index.html
https://www.m.chiba-u.ac.jp/class/meneki/